These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 9316394

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pathways of antigen processing and presentation.
    Watts C, Powis S.
    Rev Immunogenet; 1999; 1(1):60-74. PubMed ID: 11256573
    [Abstract] [Full Text] [Related]

  • 3. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM, Arnold PY, White GA, Nardella JP, Mannie MD.
    J Immunol; 1999 Nov 15; 163(10):5201-10. PubMed ID: 10553040
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The HLA system, antigen processing and presentation.
    Krensky AM.
    Kidney Int Suppl; 1997 Mar 15; 58():S2-7. PubMed ID: 9067934
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing.
    Li P, Gregg JL, Wang N, Zhou D, O'Donnell P, Blum JS, Crotzer VL.
    Immunol Rev; 2005 Oct 15; 207():206-17. PubMed ID: 16181338
    [Abstract] [Full Text] [Related]

  • 11. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C, Rogers WO, Gowda K, Doolan DL.
    Immunol Lett; 2007 Aug 15; 111(2):92-102. PubMed ID: 17604849
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bound peptide-dependent thermal stability of major histocompatibility complex class II molecule I-Ek.
    Saito K, Oda M, Sarai A, Azuma T, Kozono H.
    Biochemistry; 2004 Aug 10; 43(31):10186-91. PubMed ID: 15287746
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Small molecule modulators of MHC class II antigen presentation: mechanistic insights and implications for therapeutic application.
    Call MJ.
    Mol Immunol; 2011 Sep 10; 48(15-16):1735-43. PubMed ID: 21676462
    [Abstract] [Full Text] [Related]

  • 19. Inefficient peptide binding by cell-surface class II MHC molecules.
    Sherman MA, Weber DA, Spotts EA, Moore JC, Jensen PE.
    Cell Immunol; 1997 Nov 25; 182(1):1-11. PubMed ID: 9427804
    [Abstract] [Full Text] [Related]

  • 20. The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance.
    Lazarski CA, Chaves FA, Jenks SA, Wu S, Richards KA, Weaver JM, Sant AJ.
    Immunity; 2005 Jul 25; 23(1):29-40. PubMed ID: 16039577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.